Post-earnings recap
Reported
Thu, Nov 2, 2017
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Teva's earnings report showed a slight miss on EPS, which contributed to a significant drop in stock price by nearly 20%. Investors reacted negatively, likely due to concerns about the company's performance amid market challenges. The lack of guidance further added to uncertainty about future prospects.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.00 | N/A | -5.47% |
Management expressed concerns about ongoing market pressures. They highlighted their commitment to controlling costs in this challenging environment.
Management acknowledged challenges in the market.
They emphasized a focus on cost management moving forward.